FOXA1 and bladder transitional cell carcinoma: FOXA1 was observed to be downregulated in the GSE231835 dataset's cisplatin-resistant samples (Fig. 3B) and showed a significant negative correlation with YAP expression in the TCGA-BLCA dataset (Fig. 3D).